HEM Pharma Inc
KOSDAQ:376270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HEM Pharma Inc
KOSDAQ:376270
|
KR |
|
G
|
General Dynamics Corp
XMUN:GDX
|
US |
|
M
|
Memphasys Ltd
ASX:MEM
|
AU |
|
P
|
Purple Beverage Company Inc
OTC:PPBV
|
US |
|
I
|
Italgas SpA
F:I10
|
IT |
|
Dabur India Ltd
BSE:500096
|
IN |
|
K
|
Korn Ferry
F:KFY
|
US |
|
C
|
China Resources Beer Holdings Co Ltd
XMUN:CHK
|
HK |
|
Decibel Cannabis Company Inc
OTC:DBCCD
|
CA |
|
F
|
Fife Capital Corp
XTSX:FFC.P
|
CA |
|
ENvue Medical Inc
OTC:FEED
|
US |
Bankruptcy Probability
HEM Pharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Financial Position
| Jun 30, 2026 | 9.6B |
| Mar 31, 2026 | 12.5B |
| Dec 31, 2025 | 5.3B |
| Sep 30, 2025 | 5.3B |
| Jun 30, 2026 | 1.6B |
| Mar 31, 2026 | 1.5B |
| Dec 31, 2025 | 273.5m |
| Sep 30, 2025 | 273.5m |
| Jun 30, 2026 | 12.1B |
| Mar 31, 2026 | 12.5B |
| Dec 31, 2025 | 11.9B |
| Sep 30, 2025 | 11.9B |
Solvency Ratios
Solvency Ratios Comparison
HEM Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
H
|
HEM Pharma Inc
KOSDAQ:376270
|
183.6B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
207.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
103.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
91.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
55.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
HEM Pharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, HEM Pharma Inc has total debt of 12.1B KRW. This includes both short-term (7.4B KRW) and long-term (4.7B KRW) debt.
You can find a full breakdown on its Balance Sheet.